Learn about the ISN’s work in advocacy below.
ISN takes stage at WHO meeting in Geneva
ISN recently participated in the 144th World Health Organization (WHO) Executive Board meeting that took place in Geneva, Switzerland, from January 24 to February 1st, 2019. This was a valuable opportunity to highlight the case of kidney disease worldwide, calling for integrated action on prevention, early detection and management. During the meeting, ISN was asked to...
Next stage of ESKD strategic plan
End-stage Kidney Disease (ESKD) Summit Working Group leaders are meeting at the American Society of Nephrology (ASN) Kidney Week to begin planning the implementation of the ESKD strategic plan to improve worldwide access to integrated ESKD care. Key activities have been identified and prioritized across eight themes: Estimates of ESKD Burden and Treatment Coverage; Advocacy;...
Valuable partners team up with WCN 2019
We are happy to announce our partnership with Amgen, Astra Zeneca, Baxter and Danone Nutricia Research for the upcoming ISN World Congress of Nephrology (WCN) 2019, taking place from April 12 to 15, 2019 in Melbourne, Australia. These are just a few of several valuable sponsors who have supported previous editions of our congress and...
UN High-Level meeting 2018: targeted action on kidney disease
Health is a political choice. So, it is fitting that global health was on the agenda of last month's United Nations (UN) High-Level meeting on the prevention and control of non-communicable diseases (NCDs) at the 43rd UN General Assembly. The ISN was privileged to be the only kidney group to be invited, along with civic...